Лечение девочек с задержкой полового развития
Лечение при ЗПР должно быть направлено на устранение фонового заболевания, явившегося причиной отсутствия или позднего появления признаков полового созревания. Независимо от характера заболевания можно назначить заместительную гормональную терапию эстрогенами, а в дальнейшем терапию эстроген-гестагенными препаратами в циклическом режиме. При жела-
нии иметь детей пациентке с гонадотропным ги-погонадизмом, обусловленным поражением гипоталамо-гипофизарной системы, для индуцирования овуляции назначают инъекции ХГ в комбинации с менопаузальным гонадотропином (МГ). При гипоталамическом гипогонадизме может быть назначена также пульсирующая терапия гонадотропином в цирхоральном режиме (Claman u. Seibel, 1990; Filicori et al, 1994; Gindoff и. Jewelewicz, 1985).
У девушек, как правило, вначале проводят заместительную эстрогенную терапию. Ее назначают с костного возраста 11—12 лет конъютированными эстрогенными препаратами, начиная с дозы 0,3 мг/сут (в качестве альтернативы можно назначить эстрадиола валерат в дозе 0,2 мг/сут) в течение 6 мес. В течение следующих 6 мес дозу конъ-югированных эстрогенов можно повысить до 0,6 мг/сут (дозу эстрадиола валерата — до 0,5 мг/сут). При проведении терапии в циклическом режиме эстрогены назначают с 1-го по 25-й день, а геста-гены — с 14-го по 25-й. Из гестагенов обычно используют дидрогестерон (10 мг/сут), медроксип-рогестерона ацетат (2,5—5 мг/сут) или хлормади-нона ацетат (2 мг/сут). На второй год терапии дозу конъюгированных эстрогенов можно повысить до 0,9—1,25 мг/сут (эстрадиола валерата до 1—1,5 мг/сут). На третий год лечения дозу эстрогенов доводят до конечной, а именно: конъюгированных эстрогенов до 1,25 мг/сут, эстрадиола валерата до 2 мг/сут (Stolecke, 1998). При сочетанной гипоталамо-гипофизарной недостаточности заместительную эстроген-гестагенную терапию комбинируют с назначением других гормонов: гидрокортизона, L-тироксина и гормона роста.
4.5. Заключение
Несмотря на прогресс, достигнутый в диагностике и лечении преждевременного полового развития у девочек и гипогонадизма у девушек, мы еще далеки от возможности ранней диагностики этих состояний и восстановления нарушенных физиологических механизмов у этих пациенток.
Препараты — антагонисты гонадолиберина замедленного действия представляют собой класс веществ, которые благодаря отсутствию у них стимулирующего эффекта гонадолиберина, обычно проявляющегося в начале терапии этим гормоном, могут заменить агонисты гонадолиберина в лечении девочек с преждевременным поло-
вым развитием. В ближайшие годы мы надеемся оптимизировать временные особенности схемы терапии (завершение лечения агонистами гона-долиберина), а также усовершенствовать методы дифференциальной диагностики гипогонадотроп-ного гипогонадизма и конституциональной ЗПР.
Литература
Albright A. L., Lee P.A. Neurosurgical treatment of hypothalamic hamartomas causing precocious puberty // J. Neurosurg. - 1993. - Vol. 78. - P. 77-82.
Antoniazzi F., Cisternino M., Nizzoli G. etal. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments // Acta Paediatr. - 1994. - Vol. 83. - P. 1052— 1056.
Apter D., Biitzow T.L., Laughlin G.A., Yen S.S.C. Go-nadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins // J. Clin. Endocrinol. Metab. - 1993. - Vol. 76. - P. 940-949.
Arrigo Т., Cisternino M., Galluzzi F. et al. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty // Eur. J. Endocrinol. — 1999. — Vol. 141, No. 2. - P. 140-144.
Attie KM., Ramirez N.R., Conte F.A. et al. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids // J. Clin. Endocrinol. Metab. — 1990. — Vol. 71. - P. 975-983.
Balagura S., Shulman K, Sobel E.H. Precocious puberty of cerebral origin // Surg. Neurol. — 1979. — Vol. 11. — P. 315-326.
Bay ley N., Pinneau S.R. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards // J. Pediatr. - 1952. - Vol. 40. - P. 423-441.
Beas F., Vargas L., Spada R.P., Merchak N. Pseudopre-cocious puberty in infants caused by a dermal ointment containing estrogens // Ibid. — 1969. — Vol. 75. — P. 127— 130.
Beck W., Wuttke W. Diurnal variations of plasma luteinizing hormone, follicle-stimulating hormone, and prolactin in boys and girls from birth to puberty // J. Clin. Endocrinol. Metab. - 1980. - Vol. 50. - P. 635-639.
Benedict P. Endocrine features in Albright's syndrome (fibrous dysplasia of bone) // Metabolism. — 1962. — Vol. 11. - P. 30-45.
Bernaschek G, Lubec G, Schaller A. Sonographische Untersuchungen uber das Wachstum von Uterus und Ova-
rien zwischen dem 1.-14. Lebensjahr//Geburtshilfe Frauen-heilkd. - 1984. - Bd 44. - S. 727-730.
Bertelloni S., Baroncelli G.I., Sorrentino M.C. et al. Effect of central precocious puberty and gonadotropin-re-leasing hormone analogue treatment on peak bone mass and final height in females // Eur. J. Pediatr. — 1998. — Vol. 157, No. 5. - P. 363-367.
Betterle C, Rossi A., Dalla Pria S. et al. Premature ovarian failure: autoimmunity and natural history // Clin. Endocrinol. (Oxf). - 1993. - Vol. 39, No. 1. - P. 35-43.
Bhettay E., Bonnici F. Pure oestrogen-secreting feminizing adrenocortical adenoma // Arch. Dis. Child. — 1977. — Vol. 52. - P. 241-243.
Bourguignon J.-P., Gerard A., Alvarez Gonzalez M.L. et al. Effects of changes in nutritional conditions on timing of puberty: clinical evidence from adopted children and experimental studies in the male rat // Horm. Res. — 1992a. — Vol. 38. - Suppl. 1. - P. 97-105.
Bourguignon J.-P., Gerard A., Alvarez Gonzalez. M.L., Franchimont P. Neuroendocrine mechanism of onset of puberty. Sequential reduction in activity of inhibitory and facilitatory N-methyl-D-aspartate receptors // J. Clin. Invest. - 1992b. - Vol. 90. - P. 1736-1744.
Boyar R.M., Finkelstein J. W., David R. et al. Twenty-four hour pattern of plasma luteinizing hormone and follicle-stimulating hormone in sexual precocity // N. Engl. J. Med. - 1974. - Vol. 289. - P. 282-286.
Brann D. W., Mahesh V.B. Excitatory amino acids: function and significance in reproduction and neuroendocrine regulation // Front. Neuroendocrinol. — 1994. — Vol. 15, No. 1. - 3-49.
Bundscherer F., Deeg K.H. Die sonographische Beurtei-lung der Uterasentwicklung im Kindesalter // Monatsschr. Kinderheilkd. - 1988. - Bd 136. - S. 246-250.
Carel J.C., Roger M., Ispas S. et al. Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of De-capeptyl in Precocious Puberty // J. Clin. Endocrinol. Metab. - 1999. - Vol. 84, No. 6. - P. 1973-1978.
Chaussain J.L., Swaenepoel C, Bost M. et al. Growth and ovarian function in girls with central precocious puberty after interruption of LHRH agonist therapy // Sexual Precocity. Etiology, Diagnosis, and Management / Eds G.D. Grave, G.B. Cutler Jr. - N.Y.: Raven Press, 1993. - P. 55-59.
Cisternino M., Arrigo Т., Pasquino A.M. et al. Etiology and age incidence of precocious puberty in girls: a multicentric study // J. Pediatr. Endocrinol. Metab. — 2000. — Vol. 13. - Suppl. 1. - P. 695-701.
Cisternino M., Pasquino A.M., Bozzola M. et al. Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate // Horm. Res. - 1992. - Vol. 37. - P. 86-90.
Claman P., Seibel ММ. Ovulation induction: GnRH // Infertility / Ed. M.M. Seibel. — Norwalk: Appleton and Lange, 1990. - P. 333-350.
Comite F., Schiebinger R.J., Albertson B.D. et al. Isosex-ual precocious pseudopuberty secondary to a feminizing adrenal tumor // J. Clin. Endocrinol. Metab. — 1984. — Vol. 58. - P. 435-440.
Conte F.A., Grumbach MM., Kaplan S.L. A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis // Ibid. — 1975. — Vol. 40. — P. 670-674.
Conte F.A., Grumbach MM., Kaplan S.L., Reiter E.O. Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty // Ibid. - 1980. - Vol. 50. - P. 163-168.
Cronen P. W., Nagaraj H.S. Ovarian tumors in children // South. Med. J. - 1988. - Vol. 81. - P. 464-468.
Cronje H.S., Niemand I., Bam R.H., Woodruff J. D. Granulosa and theca cell tumors in children: a report of 17 cases and literature review // Obstet. Gynecol. Surv. — 1998. - Vol. 53, No. 4. - P. 240-247.
Dewhurst C.J. Precocious sexual development of ovarian origin // The Gynecology of Childhood and Adolescence // Eds J.W. Huffman, C.J. Dewhurst, V.J. Capraro. — Philadelphia: Saunders, 1981. - P. 362-367.
Distler W., Kuhrke H., Jurgens H., Graf M. Puberty and ovarian function following cytostatic therapy in childhood // Geburtshilfe Frauenheilkd. - 1986. - Bd 46. - S. 237-241.
Doring G.K. Uber die relative Sterilitat in den Jahren nach der Menarche // Ibid. - 1963. - Bd 23. - S. 30-36.
Dorr H.G., Sippell W.G., Drop S.L.S. et al. Evidence of 11 -beta-hydroxylase deficiency in childhood adrenocortical tumors. The plasma corticosterone/11 -deoxycorticosterone ratio as a possible marker for malignancy // Cancer. — 1987. — Vol. 60. - P. 1625-1629.
Drop S.L.S., Braining G.J., Visser H.K.A., Sippell W.G. Prolonged galactorrhoea in a 6-year-old girl with isosexual precocious puberty due to a feminizing adrenal tumour // Clin. Endocrinol. (Oxf). - 1981. - Vol. 15. - P. 3743.
Ehren I.M., Mahour G.H., Isaacs H. Jr. Benign and malignant ovarian tumors in children and adolescents. A review of 63 cases // Am. J. Surg. - 1984. - Vol. 147. - P. 339-344.
Feuillan P.P., Foster СМ., Pescovitz O.H. et al. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone // N. Engl. J. Med. - 1986. - Vol. 315. - P. 1115-1119.
Feuillan P.P., Jones J., Cutler G.B. Jr. Long term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome // J. Clin. Endocrinol. Metab. — 1993. - Vol. 77. - P. 647-651.
Filicori M., Flamigni C, Dellai P. et al. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles // Ibid. —
1994. - Vol. 79. - P. 1215-1220.
Forest M.G Pituitary gonadotropin and sex steroid secretion during the first two years of life // Control of the Onset of Puberty / Eds M.M. Grumbach, P.C. Sizonenko, M.L. Aub-ert. - Baltimore: Williams and Wilkins, 1990. - P. 451-478.
Foster СМ., Ross J.L., Shawker T. et al. Absence of pubertal gonadotropin secretion in girls with McCune-Al-bright syndrome // J. Clin. Endocrinol. Metab. — 1984. — Vol. 58. - P. 1161-1165.
Gay V.L., Plant TM. N-Methyl-D,L-aspartate elicits hypothalamic gonadotropin-releasing hormone release in prepubertal male rhesus monkeys (Macaca mulatta) // Endocrinology. - 1987. - Vol. 120. - P. 2289-2296.
Gindoff P.R., Jewelewicz R. Use of gonadotropin in ovulation induction // N.Y. State J. Med. - 1985. - Vol. 85. -P. 580-584.
Girard J., Baumann J.В., Buhler U. et al. Cyproterone acetate and ACTH adrenal function // J. Clin. Endocrinol. Metab. - 1978. - Vol. 41. - P. 581-586.
Gluckman P.D., Marti-Henneberg C, Kaplan S.L., Grumbach M.M. Hormone ontogeny in the ovine fetus: XIV. The effects of 17p-estradiol infusion on fetal plasma gonadotropins and prolactin and the maturation of sex steroid-dependent negative feedback // Endocrinology. — 1983. — Vol. 112. - P. 1618-1623.
Greulich W. W., Pyle S.L Radiographic atlas of skeletal development of the hand and wrist. — 2nd ed. — Stanford: Stanford University Press, 1959.
Griffin L.J., Cole T.J., Duncan K.A. et al. Pelvic ultrasound measurements in normal girls // Acta Paediatr. —
1995. - Vol. 84. - P. 536-543.
Grumbach M.M. True or central precocious puberty // Current Therapy in Endocrinology and Metabolism / Eds D.R. Krieger, C.W. Bardin. - St Louis: B.C. Decker; C.V. Mosby, 1985. - P. 4-8.
Grumbach MM., Kaplan S.L. Recent advances in the diagnosis and management of sexual precocity // Acta Paediatr. Jpn. - 1988. - Vol. 30. - Suppl. - P. 155-175.
Grumbach MM., Kaplan S.L. The neuroendocrinology of human puberty: an ontogenetic perspective // Control of the Onset of Puberty / Eds M.M. Grumbach, P.C. Sizonenko, M.L. Aubert. — Baltimore: Williams and Wilkins, 1990. - P. 1-68.
Grumbach MM., Styne DM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders // Williams Textbook of Endocrinology /Eds J.D. Wilson, D.W. Foster, H.M. Kronenberg, P.R. Larsen. — Philadelphia; Lond.; Toronto: W.B. Saunders, 1998. - P. 1509-1625.
Harris D.A., Van Vliet G., Egli C.A. et al. Somatome-din-C in normal puberty and in true precocious puberty
before and after treatment with a potent luteinizing hormone-releasing hormone agonist // J. Clin. Endocrinol. Metab. - 1985. - Vol. 61. - P. 152-159.
Hauffa B.P. Klinische und laboranalytische Messwerte // Endokrinologie des Kindes- und Jugendalters. 3. Aufl. / Stolecke H. (Hrsg). — Berlin; Heidelberg; N.Y.: Springer, 1997. - S. 549-603.
Hauffa B.P. Pubertas tarda // Der jugendliche Patient / Dorr H.G., Rascher W. (Hrsg). — Munchen: Urban and Fischer, 2001.
Hauffa B.P., Havers W., Stolecke H. Short-term effects of testolactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with Mc-Cune-Albright syndrome // Helv. Paediatr. Acta. — 1987. — Vol. 42. - P. 471-480.
Hazum E., Conn P.M. Molecular mechanism of gona-dotropin-releasing hormone (GnRH) action. I. The GnRH receptor // Endocr. Rev. - 1988. - Vol. 9. - P. 379-386.
Heger S., Partsch C.J., Sippell W.G. Long-term outcome after deport gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function // J. Clin. Endocrinol. Metab. — 1999. — Vol. 84, No. 12. - P. 4583-4590.
Heinze F., Teller W.M., Fehm H.L., Joos A. The effect of cyproterone acetate on adrenal cortical function in children with precocious puberty // Eur. J. Pediatr. — 1978. — Vol. 128. - P. 81-88.
Helge H. Fruhreife // Monatsschr. Kinderheilkd. — 1973. - Vol. 121. - P. 636-646.
Hertz R- Accidental ingestion of estrogens by children // Pediatrics. - 1958. - Vol. 21. - P. 203-206.
Huckle W.R., Conn P.M. Molecular mechanism of gonadotropin-releasing hormone action. II. The effector system // Endocr. Rev. - 1988. - Vol. 9. - P. 387-395.
Jung H., Carmel P., Schwartz M.S. et al. Some hypothalamic hamartomas contain transforming growth factor a, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons//J. Clin. Endocrinol. Metab. - 1999. - Vol. 84, No. 12. - P. 4695-4701.
Kaplan S.L., Grumbach M.M. Pituitary and placental gonadotropins and sex steroids in the human and sub-human primate fetus // Clin. Endocrinol. Metab. — 1978. — Vol. 7. - P. 487-511.
Kaplan S.L., Grumbach M.M. Clinical review 14: Pathophysiology and treatment of sexual precocity // J. Clin. Endocrinol. Metab. - 1990. - Vol. 71. - P. 785-789.
Kato K., Fujimoto M., Hibi I. et al. The long-term effect of cyproterone acetate on growth in girls with idiopathic precocious puberty. Androcur Study Group in Japan // Eur. J. Pediatr. - 1993. - Vol. 152, No. 4. - P. 297-300.
Kaufman F.R., Xu Y.K., Ng W.G., Donnell G.N. Correlation of ovarian function with galactose-1-phosphate uridyl
transferase levels in galactosemia // J. Pediatr. — 1988. — Vol. 112. - P. 754-756.
Kauli R., Galatzer A., Kornreich L. et al. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue — a comparative study with re-evaluation of predictions by the Bayley-Pinneau method // Horm. Res. - 1997. - Vol. 47, No. 2. - P. 54-61.
Kelch R.P. Management of precocious puberty // N. Engl. J. Med. - 1985. - Vol. 312. - P. 1057-1058.
Kletter G.B., Kelch R.P. Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty // J. Clin. Endocrinol. Metab. — 1994. -Vol. 79. - P. 331-334.
Kulin H.E., Grumbach M.M., Kaplan S.L. Changing sensitivity of the pubertal gonadal hypothalamic feedback mechanism in man // Science. — 1969. — Vol. 166. — P. 1012-1013.
Kulin H.E., Grumbach M.M., Kaplan S.L. Gonadal-hypothalamic interaction in prepubertal and pubertal man: effect of clomiphene citrate on urinary follicle-stimulating hormone and luteinizing hormone and plasma testosterone // Pediatr. Res. - 1972. - Vol. 6. - P. 162-171.
Largo R.H., Prader A. Pubertal development in Swiss girls // Helv. Paediatr. Acta. - 1983. - Vol. 38. - P. 229-243.
Luna A.M., Wilson D.M., Wibbelsman C.W. et al. Somatomedins in adolescence: a cross-sectional study of the effect of puberty on plasma insulin-like growth factor I and II levels // J. Clin. Endocrinol. Metab. - 1983. - Vol. 57. -P. 268-271.
Lyon A.J., De-Bruyn R., Grant D.B. Transient sexual precocity and ovarian cysts // Arch. Dis. Child. — 1985. — Vol. 60. - P. 819-822.
Ma Y.J., Hill D.F., Creswick K.E. et al. Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development // J. Neurosci. - 1999. - Vol. 19, No. 22. -9913-9927.
Mahachoklertwattana P., Kaplan S.L., Grumbach M.M. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history // J. Clin. Endocrinol. Metab. - 1993. - Vol. 77. - P. 118-124.
Marshall W.A., Tanner J.M. Puberty// Human Growth / Eds F. Falkner, J.M. Tanner. - N.Y.: Plenum. 1986. -P. 171-209.
Michael R.P., Zumpke D. Behavioural changes associated with puberty in higher primates and the human // Control of the Onset of Puberty / Eds M.M. Grumbach, P.C. Sizonenko, M.L. Aubert. — Baltimore: Williams and Wilkins. 1990. - P. 574-587.
Money J., Clopper R.R. Jr. Psychosocial and psychosex-ual aspects of errors of pubertal onset and development // Hum. Biol. - 1974. - Vol. 46. - P. 173-181.
Mouridsen S.E., Larsen F.W. Psychological aspects of precocious puberty. An overview // Acta Paedopsychiatr. — 1992. - Vol. 55. - P. 45-49.
Murrain D., Dewhurst J., Grant D.B. Premature me-narche: a follow-up study // Arch. Dis. Child. — 1983. — Vol. 58. - P. 142-143.
Noonan J.A. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease // Am. J. Dis. Child. - 1968. - Vol. 116. - P. 373-380.
Oerter K.E., Manasco P., Barnes KM. et al. Adult height in precocious puberty after long-term treatment with deslorelin // J. Clin. Endocrinol. Metab. - 1991. - Vol. 73. - P. 1235-1240.
Ogilvy'Stuart A.L., Clark D.J., Wallace W.H.B. et al. Endocrine deficit after fractionated total body irradiation // Arch. Dis. Child. - 1992. - Vol. 67. - P. 1107-1110.
Ohlsson C, Isgaard J., Tornell J. et al. Endocrine regulation of longitudinal bone growth // Acta Paediatr. — 1993. — Vol. 82. - Suppl. 391. - P. 33-40.
Oostdijk W., Rikken В., Schreuder S. et al. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist // Arch. Dis. Child. — 1996. - Vol. 75, No. 4. - P. 292-297.
Orsini L.F., Salardi S., Pilu G. et al. Pelvic organs in premenarcheal girls: real-time ultrasonography // Radiology. - 1984. - Vol. 153. - P. 113-116.
Parker L.N. Adrenarche // Endocrinol. Metabol. Clin. North Am. - 1991. - Vol. 20. - P. 71-83.
Partsch C.J., Hummelink R., Lorenzen F., Sippell W.G Bedeutung und Charakteristika des LHRH-Testes in der Diagnostik der vorzeitigen Pubertatsentwicklung bei Mad-chen: Der stimulierte LH-FSH-Quotient differenziert zwis-chen zentraler Pubertas praecox und pramaturer Thelarche. Die deutsche Decapeptyl-Depot-Studiengrappe // Monatss-chr. Kinderheilkd. - 1989. - Bd 137. - S. 284-288.
Partsch C.J., Hummelink R., Sippell W.G. Reference ranges of lutropin and follitropin in the luliberin test in prepubertal and pubertal children using a monoclonal immunoradio-metric assay // J. Clin. Chem. Clin. Biochem. — 1990. — Vol. 28. - P. 49-52.
Paul D., Conte F.A., Grumbach M.M., Kaplan S.L. Dong term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years // J. Clin. Endocrinol. Metab. - 1995. - Vol. 80. - P. 546-551.
Perheentupa J., Miettinen A. Type 1 autoimmune polyglandular disease // Ann. Med. Interne (Paris). — 1999. — Vol. 150, No. 4. - P. 313-325.
Pescovitz O.H., Flench K.D., Barnes KM. et al. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone // J. Clin. Endocrinol. Metab. - 1988. - Vol. 67. - P. 474-479.
Prader A. Pubertatsentwicklung: Was ist normal? Was 1st auffallend oder pathologisch? Einige grundsatzliche Be-trachtungen // Helv. Paediatr. Acta. - 1983. - Vol. 38. -P. 197-202.
Prader A. Growth and development // Clinical Endocrinology. Theory and Practice / Ed. A. Labhart. — Berlin; Heidelberg; N.Y.: Springer, 1986a. - P. 1013-1059.
Prader A. Physiologisches, pathologisches und manipuli-ertes Korperwachstum // Monatsschr. Kinderheilkd. — 1986b. - Vol. 134. - P. 292-301.
Proos L.A. Anthropometry in adolescence — secular trends, adoption, ethnic and environmental differences // Horm. Res. - 1993. - Vol. 39. - Suppl. 3. - P. 18-24.
Ranke M.B., Chavez- Meyer H., Blank B. et al. Spontaneous growth and bone age development in Turner syndrome: results of a multicentric study 1990 // Turner Syndrome: Growth Promoting Therapies / Eds MB. Ranke, R.G. Rosenfeld. — Amsterdam: Elsevier Science Publishers, 1990. - P. 101-106.
Regis J., Bartolomei F., De Foffol B. et al. Gamma knife surgery for epilepsy related to hypothalamic hamartomas // Neurosurgery. - 2000. - Vol. 47, No. 6. - P. 1343-1351.
Rieth KG, Comite F, Shawker F.H., Cutler G.B. Jr. Pituitary and ovarian abnormalities demonstrated by CT and ultrasound in children with features of the McCune-Albright syndrome // Radiology. - 1984. - Vol. 153. - P. 389-393.
Riley W.J. Autoimmune polyglandular syndromes // Horm. Res. - 1992. - Vol. 38. - Suppl. 2. - P. 9-15.
Roche A.F. The final phase of growth in stature // Growth, Genetics and Hormones. — 1989. — Vol. 5. — P. 4—6.
Rosenfeld J. V., Harvey A.S., Wrennall J. et al. Transcallosal resection of hypothalamic hamartomas, with control of seizures, in children with gelastic epilepsy // Neurosurgery. - 2001. - Vol. 48, No. 1. - P. 108-118.
Rosenfleld R.L, Furlanetto R., Bock D. Relationship of somatomedin-C concentrations to pubertal changes // J. Pediatr. - 1983. - Vol. 103. - P. 723-728.
Roth H., Daum R., Benz G., Schqfer K. Rare ovarian tumors in childhood // Eur. J. Pediatr. Surg. — 1991. — Vol. 1. - P. 210-215.
Saenz de Rodriguez C.A., Bongiovanni A.M., Conde de Borrego L. An epidemic of precocious development in Puerto Rican children // J. Pediatr. - 1985. - Vol. 107. - P. 393-396.
Saggese G, Bertelloni S., Baroncelli G.I. et al. Reduction of bone density: an effect of gonadotropin-releasing hormone analogue treatment in central precocious puberty // Eur. J. Pediatr. - 1993. - Vol. 152. - P. 717-720.
Salardi S., Orsini L.F., Cacciari E. et al. Pelvic ultrasonography in premenarcheal girls: relation to puberty and sex hormone concentrations // Arch. Dis. Child. — 1985. — Vol. 60. - P. 120-125.
Salardi S., Orsini L.F., Cacciari E. et al. Pelvic ultrasonography in girls with precocious puberty, congenital adrenal hyperplasia, obesity, or hirsutism // J. Pediatr. — 1988. - Vol. 112. - P. 880-887.
Schoevaart C.E., Drop S.L., Often B.J. et al. Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty // Horm. Res. - 1990. - Vol. 34. - P. 197-203.
Schwanzel-Fukuda M., Jorgenson K.L., Bergen H.T. et al. Biology of normal luteinizing hormone-releasing hormone neurons during and after their migration from olfactory placode // Endocr. Rev. - 1992. - Vol. 13. - P. 623-634.
Shalet S.M., Crowne E.C., Didi M.A. et al. Irradiation-induced growth failure // Baillieres Clin. Endocrinol. Metab. - 1992. - Vol. 6. - P. 513-526.
Sharland M., Burch M., McKenna W.M., Paton M.A. A clinical study of Noonan syndrome // Arch. Dis. Child. — 1992. - Vol. 67. - P. 178-183.
Shawker Т.Н., Comite F., Rieth KG et al. Ultrasound evaluation of female isosexual precocious puberty // J. Ultrasound Med. - 1984. - Vol. 3, No. 7. - P. 309-316.
Sklar C.A., Conte F.A., Kaplan S.L., Grumbach M.M. Human chorionic gonadotropin-secreting pineal tumor: relation to pathogenesis and sex limitation of sexual precocity // J. Clin. Endocrinol. Metab. - 1981. - Vol. 53. -P. 656-660.
Sonis W.A., Comite F., Blue J. et al. Behaviour problems and social competence in girls with true precocious puberty // J. Pediatr. - 1985. - Vol. 106. - P. 156-160.
Sorgo W., Kiraly E., Haupenthal M. et al. Precocious puberty (PP): effects on growth in patients treated with cyproterone acetate (CYP) // Acta Endocrinol. (Copenh.) Suppl. - 1993. -Vol. 111. - P. 1.
Stivel M.S., Kauli R., Kaufman H., Laron Z. Adrenocortical function in children with precocious sexual development during treatment with cyproterone acetate // Clin. Endocrinol. (Oxf). - 1982. - Vol. 16. - P. 163-169.
Stolecke H. Storungen der Pubertatsentwicklung // En-dokrinologie des Kindes- und Jugendalters. 3. Aufl. / Stolecke H. (Hrsg). - Berlin; Heidelberg; N.Y.: Springer, 1997. - S. 378-398.
Stolecke H. Sexualsteroide bei Ullrich-Turner-Syndrom und Panhypopituitarismus. 2. Aufl. — Ankum-Kettenka-mp: Verlag Dokument u Bild, 1998.
Styne D.M., Harris D.A, Egli C.A. et al. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis // J. Clin. Endocrinol. Metab. — 1985. — Vol. 61. - P. 142-151.
Tanaka Т., Hibi L, Kato К et al. Two-year results of sustained-release leuprorelin acetate (TAP-144-SR) treatment in children with central precocious puberty // Clin. Pediatr. Endocrinol. - 1993. - Vol. 2. - P. 49-58.
Tanner J.M. Growth at adolescence. — 2nd ed. — Oxford; Edinburgh: Blackwell Scientific Publications, 1962.
Tanner J.M., Eveleth P.B. Variability between populations in growth and development at puberty // Puberty, biologic and psychosocial components / Ed. S.R. Berenberg. — Leiden: Kluwer Academic Publishers, 1975. - P. 256-273.
Tanner J.M., Whithouse R.H., Marshall W.A. et al. Assessment of skeletal maturity and prediction of adult height (TW 2 method). - N.Y.: Academic Press, 1975.
Tuvemo Т., Gustafsson J., Proos L.A. Growth hormone treatment during suppression of early puberty in adopted girls. Swedish Growth Hormone Advisory Group // Acta Paediatr. - 1999. - Vol. 88, No. 9. - P. 928-932.
Van Wieringen J.C. Secular Growth Changes // Human Growth / Eds F. Falkner, M. Tanner. — NY.: Plenum Publishers, 1986. - P. 307-331.
Van Wieringen J.C, Wafelbakker F., Verbrugge H.P., de Haas J.H. Growth Diagrams 1965 Netherlands: Second National Survey on 0—24 year olds. — Groningen: Wolters-Noordhoff Publishing, 1971.
Van Wyk J.J., Grumbach M.M. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback // J. Pediatr. - 1960. - Vol. 57. - P. 416-435.
Virdis R., Street M.E., Zampolli M. et al. Precocious puberty in girls adopted from developing countries // Arch. Dis. Child. - 1998. - Vol. 78, No. 2. - P. 152-154.
Weinstein L.S., Shenker A., Gejman P. V. et al. Activating mutations of the stimulatory G protein in the Mc-Cune-Albright syndrome (see comments) // N. Engl. J. Med. - 1991. - Vol. 325. - P. 1688-1695.
Winter J.S.D., Faiman C, Hobson W.C et al. Pituitary-gonadal relations in infancy: I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee // J. Clin. Endocrinol. Metab. — 1975. — Vol. 40. - P. 545-551.
Winter J.S.D., Hughes LA., Reyes F.I., Faiman С Pitu-itary-gonadal relations in infancy. II. Patterns of serum gonadal steroid concentrations in man from birth to two years of age // Ibid. - 1976. - Vol. 42. - P. 679.
Yanovski J.A., Nelson LM., Willis E.D., Cutler G.B. Jr. Repeated, childhood vaginal bleeding is not always precocious puberty// Pediatrics. - 1992. - Vol. 89. - P. 149-151.
Zaatreh M., Tennison M., Greenwood R.S. Successful treatment of hypothalamic seizures and precocious puberty with GnRH analogue // Neurology. - 2000. - Vol. 55, No. 12. - P. 1908-1910.
Дата добавления: 2014-12-11 | Просмотры: 1936 | Нарушение авторских прав
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 |
|